Collegium Pharmaceutical, Inc.COLLNASDAQ
Loading
Year-over-year research & development expense growth
Latest
0.00%
↑ 100% vs avg
Percentile
P50
Within normal range
Average
-10.14%
Historical baseline
| Period | Value |
|---|---|
| 2025 | 0.00% |
| 2024 | 0.00% |
| 2023 | -100.00% |
| 2022 | -57.86% |
| 2021 | -3.28% |
| 2020 | -5.49% |
| 2019 | 19.39% |
| 2018 | 1.04% |
| 2017 | -42.65% |
| 2016 | 87.44% |